VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher ...

The drugmaker should significantly mitigate its most important risk as it develops new products.

Haisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more. The ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

One offers concentrated exposure to 29 pharma giants with lower volatility, while the other provides broader diversification ...

The life sciences sector, encompassing pharmaceuticals, biotechnology, and medical devices, is experiencing unprecedented advancements driven by scientific innovation. Technologies such as artificial ...

This risk is weighing on the stock.

Sovereign capital, guaranteed offtake, and localization mandates are reshaping how biotech deals get structured in the Gulf, ...

WHX to take place from 25–28 January 2027 across Dubai Exhibition Centre, Expo City and Dubai World Trade Centre By ...

December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...

DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

How data-driven decision-making and integrated R&D systems can help India’s pharmaceutical and biotechnology sectors improve ...